Cargando…

Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease

Depression is a common comorbidity of type 2 diabetes mellitus (T2DM). T2DM with comorbid depression increases the risk of cardiovascular events and death. Depression and T2DM and its macrovascular complications exhibited a two-way relationship. Regarding treatment, antidepressants can affect the de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Mengmeng, Li, Yiwen, Luo, Binyu, Cui, Jing, Liu, Yanfei, Liu, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960118/ https://www.ncbi.nlm.nih.gov/pubmed/35360021 http://dx.doi.org/10.3389/fcvm.2022.861110

Ejemplares similares

Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective
por: Cui, Jing, et al.
Publicado: (2021)

Oral, Tongue-Coating Microbiota, and Metabolic Disorders: A Novel Area of Interactive Research
por: Li, Yiwen, et al.
Publicado: (2021)

Development and Validation of Risk Prediction Model for New-Onset Diabetes After Percutaneous Coronary Intervention (NODAP): A Study Protocol for a Retrospective, Multicenter Analysis
por: Li, Yiwen, et al.
Publicado: (2021)

Intermittent Hypoxia and Atherosclerosis: From Molecular Mechanisms to the Therapeutic Treatment
por: Luo, Binyu, et al.
Publicado: (2022)

A Nomogram for Predicting Survival in Patients With Colorectal Cancer Incorporating Cardiovascular Comorbidities
por: Wang, Hao, et al.
Publicado: (2022)

Rationale and design of the improving Care for Cardiovascular Disease in China (CCC) project: a national registry to improve management of atrial fibrillation
por: Hao, Yongchen, et al.
Publicado: (2018)

Mendelian randomization study reveals a causal relationship between serum iron status and coronary heart disease and related cardiovascular diseases
por: Liu, Fenglan, et al.
Publicado: (2023)

The oral microbiota and cardiometabolic health: A comprehensive review and emerging insights
por: Li, Yiwen, et al.
Publicado: (2022)

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
por: Xu, Shuai, et al.
Publicado: (2022)

Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?
por: Mędrek, Sabina, et al.
Publicado: (2022)

Cardiovascular imaging of women and men visiting the outpatient clinic with chest pain or discomfort: design and rationale of the ARGUS Study
por: Groepenhoff, Floor, et al.
Publicado: (2020)

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence
por: Nopp, Stephan, et al.
Publicado: (2022)

Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Crisan, Liliana, et al.
Publicado: (2019)

The Distribution of Cardiovascular-Related Comorbidities in Different Adult-Onset Cancers and Related Risk Factors: Analysis of 10 Year Retrospective Data
por: Li, Qingsong, et al.
Publicado: (2021)

QT interval is correlated with and can predict the comorbidity of depression and anxiety: A cross-sectional study on outpatients with first-episode depression
por: Tang, Mingcong, et al.
Publicado: (2022)

Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO)
por: Polverino, Francesca, et al.
Publicado: (2020)

Relationship between rheumatoid arthritis and cardiovascular comorbidity, causation or co-occurrence: A Mendelian randomization study
por: Wang, Min, et al.
Publicado: (2023)

Dietary patterns and cardiometabolic health: Clinical evidence and mechanism
por: Wang, Wenting, et al.
Publicado: (2023)

Evidence for the Benefits of Melatonin in Cardiovascular Disease
por: Tobeiha, Mohammad, et al.
Publicado: (2022)

Iloprost in COVID-19: The Rationale of Therapeutic Benefit
por: Faggioli, Paola Maria, et al.
Publicado: (2021)

Erratum: Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO)
Publicado: (2020)

Effectiveness of Yiqi Fumai lyophilized injection for acute heart failure: Rationale and design of the AUGUST-AHF cohort study
por: Zhang, Xuecheng, et al.
Publicado: (2023)

Rationale, design and protocol of a cross-sectional study on pregnancy-related cardiovascular diseases in Tanzania (PRECARDT): burden, characterisation and prognostic significance at delivery
por: Makubi, Abel, et al.
Publicado: (2021)

Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention
por: Baldassarre, Damiano, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design
por: Ali, Danish, et al.
Publicado: (2019)

Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases
por: Cai, Yuxi, et al.
Publicado: (2022)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications
por: Girard, Diane, et al.
Publicado: (2022)

Systematic Understanding of Pathophysiological Mechanisms of Oxidative Stress-Related Conditions—Diabetes Mellitus, Cardiovascular Diseases, and Ischemia–Reperfusion Injury
por: Wang, Mengxue, et al.
Publicado: (2021)

Rationale, design and study protocol of the randomised controlled trial: Diabetes Interventional Assessment of Slimming or Training tO Lessen Inconspicuous Cardiovascular Dysfunction (the DIASTOLIC study)
por: Gulsin, Gaurav Singh, et al.
Publicado: (2019)

The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis
por: Stojanovic, Dijana, et al.
Publicado: (2022)

Monosodium Glutamate-Induced Mouse Model With Unique Diabetic Retinal Neuropathy Features and Artificial Intelligence Techniques for Quantitative Evaluation
por: Liu, Yanfei, et al.
Publicado: (2022)

Design and rationale of the MyHeartMate study: a randomised controlled trial of a game-based app to promote behaviour change in patients with cardiovascular disease
por: Gallagher, Robyn, et al.
Publicado: (2019)

Proteomics and bioinformatics analysis of cardiovascular related proteins in offspring exposed to gestational diabetes mellitus
por: Pan, Hai-Tao, et al.
Publicado: (2022)

Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature
por: Varounis, Christos, et al.
Publicado: (2017)

Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
por: Graziani, Francesca, et al.
Publicado: (2021)

The Palma Echo Platform: Rationale and Design of an Echocardiography Core Lab
por: López, Luis, et al.
Publicado: (2022)

The rationale for the treatment of long-Covid symptoms – A cardiologist's view
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Metformin Protects Cardiovascular Health in People With Diabetes
por: Chen, Chong, et al.
Publicado: (2022)

Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities
por: Li, Zhiwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ge5dnlp386o8lghppfuq7tu6ki